Cart
sales@molnova.com
Calcium gluconate
CAS No. 299-28-5
Calcium gluconate( —— )
Catalog No. M13921 CAS No. 299-28-5
Calcium gluconate is a mineral supplement, manufactured by the neutralization of gluconic acid with lime or calcium carbonate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 32 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | 61 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCalcium gluconate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalcium gluconate is a mineral supplement, manufactured by the neutralization of gluconic acid with lime or calcium carbonate.
-
DescriptionCalcium gluconate is a mineral supplement, manufactured by the neutralization of gluconic acid with lime or calcium carbonate.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number299-28-5
-
Formula Weight430.37
-
Molecular FormulaC12H22CaO14
-
Purity>98% (HPLC)
-
SolubilityWater: 30 mg/mL
-
SMILESC([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Ca+2]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Drop LJ, Cullen DJ. Br J Anaesth. 1980 May;52(5):501-5.
molnova catalog
related products
-
Ceftiofur hydrochlor...
Ceftiofur HCl is a cephalosporin antibiotic, used to treat both Gram-positive and Gram-negative bacteria infection.
-
Insulin(cattle)
Insulin (insulin from the bovine pancreas) is a two-chain polypeptide hormone produced in human pancreatic cells.Insulin cattle are often used as a growth supplement for cultured cells.
-
TC-AQP1-1
TC-AQP1-1 is a blocker of the aquaporin 1 channel identified by virtual screening and inhibits water flux through hAQP1 in Xenopus laevis oocyte swelling assays at low micromolar concentrations.
